Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy
Yuning Liao, Yuan Liu, Xiaohong Xia, et al.
Theranostics (2020) Vol. 10, Iss. 8, pp. 3366-3381
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer
Laura Cato, Jonas de Tribolet-Hardy, Irene Lee, et al.
Cancer Cell (2019) Vol. 35, Iss. 3, pp. 401-413.e6
Open Access | Times Cited: 157
Therapeutic Effects of Coumarins with Different Substitution Patterns
Virginia Flores‐Morales, Ana P. Villasana-Ruíz, Idalia Garza‐Veloz, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2413-2413
Open Access | Times Cited: 91
Natural products reverse cancer multidrug resistance
Jiayu Zou, Qilei Chen, Xiao-Ci Luo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing
De Chen, Yanjie Wang, Ruixun Lu, et al.
Theranostics (2020) Vol. 10, Iss. 19, pp. 8558-8572
Open Access | Times Cited: 64
USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells
Yuning Liao, Zhenlong Shao, Yuan Liu, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 44
The Crucial Role of AR-V7 in Enzalutamide-Resistance of Castration-Resistant Prostate Cancer
Zeyuan Zheng, Jinxin Li, Yankuo Liu, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4877-4877
Open Access | Times Cited: 37
Anti-Androgen Receptor Therapies in Prostate Cancer: A Brief Update and Perspective
Jian Huang, Biyun Lin, Benyi Li
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 31
NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling
Shuaijun Ma, Y Chen, Penghe Quan, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 21
Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer
Sue Jin Moon, Byong Chang Jeong, Hwa Jin Kim, et al.
Theranostics (2020) Vol. 11, Iss. 2, pp. 958-973
Open Access | Times Cited: 41
The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression
Xiaohong Xia, Chuyi Huang, Yuning Liao, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 35
A new role of GRP75-USP1-SIX1 protein complex in driving prostate cancer progression and castration resistance
Yuning Liao, Yuan Liu, Zhenlong Shao, et al.
Oncogene (2021) Vol. 40, Iss. 25, pp. 4291-4306
Closed Access | Times Cited: 33
Selective degradation of AR-V7 to overcome castration resistance of prostate cancer
Yuan Liu, Cuifu Yu, Zhenlong Shao, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 10
Open Access | Times Cited: 33
A Comprehensive Overview of Small-Molecule Androgen Receptor Degraders: Recent Progress and Future Perspectives
Si Ha, Guoshun Luo, Hua Xiang
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16128-16154
Closed Access | Times Cited: 24
Inhibiting androgen receptor splice variants with cysteine-selective irreversible covalent inhibitors to treat prostate cancer
Thirumagal Thiyagarajan, Suriyan Ponnusamy, Dong‐Jin Hwang, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 120, Iss. 1
Open Access | Times Cited: 24
Natural quinazolinones: From a treasure house to promising anticancer leads
Hanbing Li, Gaohang Fu, Weihui Zhong
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114915-114915
Closed Access | Times Cited: 23
HSP90β Impedes STUB1‐Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma
Yuning Liao, Yuan Liu, Cuifu Yu, et al.
Advanced Science (2023) Vol. 10, Iss. 27
Open Access | Times Cited: 15
CRISPR screening reveals gleason score and castration resistance related oncodriver ring finger protein 19 A (RNF19A) in prostate cancer
Ning Zhang, Da Huang, Xiaohao Ruan, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100912-100912
Open Access | Times Cited: 14
Deubiquitination of CD36 by UCHL1 promotes foam cell formation
Xiaohong Xia, Qiong Xu, Mingke Liu, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 8
Open Access | Times Cited: 35
Post-Translational Modifications That Drive Prostate Cancer Progression
Ivana Samaržija
Biomolecules (2021) Vol. 11, Iss. 2, pp. 247-247
Open Access | Times Cited: 32
A SIX1 degradation inducer blocks excessive proliferation of prostate cancer
Yuning Liao, Wenshuang Sun, Zhenlong Shao, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 6, pp. 2439-2451
Open Access | Times Cited: 21
Hesperidin Suppresses the Proliferation of Prostate Cancer Cells by Inducing Oxidative Stress and Disrupting Ca2+ Homeostasis
Seon Ae Jeong, Changwon Yang, Jisoo Song, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1633-1633
Open Access | Times Cited: 21
Design, synthesis, and characterization of PROTACs targeting the androgen receptor in prostate and lung cancer models
Lukas Maria Gockel, Vladlena Pfeifer, Fabian Baltes, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 5
Open Access | Times Cited: 20
SNS-023 sensitizes hepatocellular carcinoma to sorafenib by inducing degradation of cancer drivers SIX1 and RPS16
Yuan Liu, Weiyao Kong, Cuifu Yu, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 4, pp. 853-864
Closed Access | Times Cited: 19
Malate initiates a proton-sensing pathway essential for pH regulation of inflammation
Yujianan Chen, Ruihua Shi, Yan Xiang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Atractylenolide I ameliorated the growth and enzalutamide resistance of castration-resistant prostate cancer by targeting KIF15
Chenglin Han, Bin Yang, Yuxuan Deng, et al.
Chinese Medicine (2025) Vol. 20, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top